Noahmed
SnapshotCompany claim
Company description not yet disclosed.
- Founded
- Not disclosed
- HQ
- Not disclosed
- Models
- 1
- Categories
- 1
ContactCompany claim
- Address
- Not disclosed
Product families
Is this your company? Claim this profile to add verified data, respond to our analysis, and upgrade claims to Verified.
Claim this profile
The MATCH 2 study, published in Respiratory Medicine, evaluated the accuracy of three-dimensional targeting during Robotic-Assisted Bronchoscopy using Noah Medical's Galaxy System. It reported 96.7% overall diagnostic yield, 96.7% tool-in-lesion confirmation via digital tomosynthesis, and 96.7% concordance with CBCT. The study involved 31 patients with peripheral pulmonary nodules.
- •96.7% overall diagnostic yield
- •96.7% tool-in-lesion confirmation using digital tomosynthesis
- •96.7% concordance between digital tomosynthesis with augmented fluoroscopy and cone-beam CT confirmation
- •Three-dimensional targeting accuracy during robotic bronchoscopy
- •Embedded digital tomosynthesis and augmented fluoroscopy
Detailed specs not disclosed.
Technology stackOur read
Inferred from product specs — click through to the technology wiki:
ResearchComputed
Product comparisonComputed
Company announcement
News and Media
The company's official social & video channels · external links
News
From third-party news outlets (China & abroad) · external links
